Celcuity Inc.

10.64+0.1400+1.33%Vol 35.62K1Y Perf -47.60%
Aug 11th, 2022 16:00 DELAYED
BID4.26 ASK11.25
Open10.68 Previous Close10.50
Pre-Market- After-Market-
 - -  - -%
Target Price
36.75 
Analyst Rating
Strong Buy 1.00
Potential %
245.40 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-20/-33/-50 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-33/-43/-62 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
99/99/98 
Income Ranking
 —    -
Price Range Ratio 52W %
31.85 
Earnings Rating
Strong Buy
Market Cap158.97M 
Earnings Date
11th Aug 2022
Alpha0.01 Standard Deviation0.25
Beta1.29 

Today's Price Range

10.3511.19

52W Range

4.8123.11

5 Year PE Ratio Range

-21.30-17.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
1.82%
1 Month
16.41%
3 Months
85.04%
6 Months
-6.58%
1 Year
-47.60%
3 Years
-46.04%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CELC10.640.14001.33
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.51-0.53-3.92
Q04 2021-0.40-0.45-12.50
Q03 2021-0.35-0.41-17.14
Q02 2021-0.38-1.11-192.11
Q04 2020-0.23-0.25-8.70
Q03 2020-0.21-0.24-14.29
Q02 2020-0.24-0.2112.50
Q01 2020-0.20-0.22-10.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.477.84Positive
9/2022 QR-0.3058.33Positive
12/2022 FY-1.2954.58Positive
12/2023 FY-1.5751.54Positive
Next Report Date-
Estimated EPS Next Report-0.47
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume35.62K
Shares Outstanding14.94K
Shares Float10.54M
Trades Count727
Dollar Volume384.45K
Avg. Volume62.43K
Avg. Weekly Volume22.89K
Avg. Monthly Volume68.57K
Avg. Quarterly Volume95.82K

Celcuity Inc. (NASDAQ: CELC) stock closed at 10.64 per share at the end of the most recent trading day (a 1.33% change compared to the prior day closing price) with a volume of 35.62K shares and market capitalization of 158.97M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 30 people. Celcuity Inc. CEO is Brian F. Sullivan.

The one-year performance of Celcuity Inc. stock is -47.6%, while year-to-date (YTD) performance is -19.33%. CELC stock has a five-year performance of %. Its 52-week range is between 4.81 and 23.113, which gives CELC stock a 52-week price range ratio of 31.85%

Celcuity Inc. currently has a PE ratio of -3.80, a price-to-book (PB) ratio of 2.26, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -59.76%, a ROC of -59.08% and a ROE of -71.86%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Celcuity Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.47 for the next earnings report. Celcuity Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Celcuity Inc. is Strong Buy (1), with a target price of $36.75, which is +245.40% compared to the current price. The earnings rating for Celcuity Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Celcuity Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Celcuity Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.73, ATR14 : 0.64, CCI20 : 138.73, Chaikin Money Flow : -0.04, MACD : 0.41, Money Flow Index : 45.19, ROC : 11.82, RSI : 63.48, STOCH (14,3) : 79.61, STOCH RSI : 0.93, UO : 63.57, Williams %R : -20.39), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Celcuity Inc. in the last 12-months were: Brian F. Sullivan (Buy at a value of $0), Richard E. Buller (Sold 2 100 shares of value $19 062 ), Richard J. Nigon (Buy at a value of $4 482)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.25
Strong Buy
1.25

Celcuity Inc.

Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-types and commercialising diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses the patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.

CEO: Brian F. Sullivan

Telephone: +1 763 392-0767

Address: 16305 36th Avenue North, Minneapolis 55446, MN, US

Number of employees: 30

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

60%40%

Bearish Bullish

50%50%


News

Stocktwits